Ackman asks for Allergan’s stockholder list (Reuters)
William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). In a regulatory filing on Monday, Ackman’s hedge fund Pershing Square Capital Management said that it has requested a complete list of holders of record in Allergan, Inc. (NYSE:AGN) to be able to “communicate with fellow stockholders of the company.”
Anaplan Gets $100 Million in Round Led by DFJ To Expand (Bloomberg)
Anaplan Inc., a provider of Web-based business planning tools, raised $100 million in a round of financing led by Draper Fisher Jurvetson to expand its business. Brookside Capital, Sands Capital Management and Workday Inc (NYSE:WDAY), as well as existing investors including Granite Ventures and salesforce.com, inc. (NYSE:CRM), participated in the round, the company said in a statement today. Anaplan, which delivers cloud-based software for companies to manage and plan their sales, operations and finance, is the latest technology startup to raise more than $100 million in a financing round.
Prosecutors Seek Sentence of More Than Five Years for SAC Employee (Wall Street Journal)
Federal prosecutors asked a judge for a stiff sentence of more than five years in prison for Michael Steinberg, a former senior employee of SAC Capital Advisors LP convicted of insider trading last year. In court documents filed late Friday, prosecutors asked U.S. District Judge Richard Sullivan to sentence Mr. Steinberg to a prison term of 5¼ to 6½ years to send a strong message to the market—more than double the time Mr. Steinberg’s lawyers recently requested.
Vinci Zafferano Turns First Profit (FINalternatives)
For the first time since its founding more than two years ago, Vinci Zafferano Capital has turned a profit. The London-based firm, headed by former Tudor Investment Corp. executives John Macfarlane and Nigel Whittaker, earned £121,243 last year, it said in a regulatory filing. The firm, which launched its first fund late in 2012, took in £1.2 million in management fees in 2013.
Oxford University wins best allocator to hedge funds (Financial News)
Of the UK’s two oldest universities, it was Cambridge that set the trend towards a more sophisticated approach to managing its endowment – it hired Nick Cavalla from Man Group as its first chief investment officer in 2007, and drafted David Swensen on to its advisory board, after his success in transforming Yale University’s endowment – and with it the way the sector manages money. However, it is Oxford that has fully embraced the US model. While Cambridge retains the bulk of its funds in public equities, with only modest allocations to private equity and absolute-return hedge funds, Oxford University Endowment Management has placed alternative investments at the centre of its strategy.
